Furosemide and Microscopic polyangiitis - a phase IV clinical study of FDA data

Summary:

Microscopic polyangiitis is reported as a side effect among people who take Furosemide (furosemide), especially for people who are male, 60+ old, also take Amlodipine, and have Eye pain.

The phase IV clinical study analyzes which people have Microscopic polyangiitis when taking Furosemide. It is created by eHealthMe based on reports of 313,719 people who have side effects when taking Furosemide from the FDA, and is updated regularly.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

What is Microscopic polyangiitis?

Microscopic polyangiitis (inflammation involving multiple blood or lymph small-vessel) is found to be associated with 31 drugs and 103 conditions by eHealthMe. Check the latest studies of Microscopic polyangiitis.



On Aug, 08, 2026

313,719 people reported to have side effects when taking Furosemide.
Among them, 12 people (0.0%) have Microscopic polyangiitis.

Could Furosemide cause Microscopic polyangiitis?

Among these 12 people:

What is the gender of people who have Microscopic polyangiitis when taking Furosemide? *

  • female: 10 %
  • male: 90 %

What is the age of people who have Microscopic polyangiitis when taking Furosemide? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Furosemide? *

  1. Amlodipine: 7 people, 58.33%
  2. Febuxostat: 4 people, 33.33%
  3. Cyclophosphamide: 4 people, 33.33%
  4. Famotidine: 4 people, 33.33%
  5. Levothyroxine Sodium: 4 people, 33.33%
  6. Ursodiol: 4 people, 33.33%
  7. Tadalafil: 4 people, 33.33%
  8. Meropenem: 4 people, 33.33%
  9. Silodosin: 4 people, 33.33%
  10. Mirabegron: 4 people, 33.33%

What are other side effects people have besides Microscopic polyangiitis? *

  1. Glomerulonephritis Rapidly Progressive (a syndrome of the kidney that is characterized by a rapid loss of renal function): 6 people, 50.00%
  2. Anaemia (lack of blood): 5 people, 41.67%
  3. Acute Kidney Failure: 4 people, 33.33%
  4. Weakness: 3 people, 25.00%
  5. Coughing Up Blood: 3 people, 25.00%
  6. Goodpasture's Syndrome (immune system mistakenly attacks and destroys healthy body tissue): 3 people, 25.00%
  7. Glomerulonephritis Acute (rapid group of conditions that affect parts of the kidneys called glomeruli): 3 people, 25.00%
  8. Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli): 3 people, 25.00%
  9. Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 3 people, 25.00%
  10. Enterobacter Sepsis (sepsis due to bacteria of the family enterobacteriaceae): 3 people, 25.00%

What are the existing conditions these people have? *

  1. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 6 people, 50.00%
  2. Seasonal Allergy (allergic condition due to certain season): 6 people, 50.00%
  3. Prostate Cancer: 6 people, 50.00%
  4. Enlarged Prostate: 6 people, 50.00%
  5. Eye Pain: 6 people, 50.00%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 33.33%
  7. Alanine Aminotransferase Decreased: 4 people, 33.33%
  8. Aspartate Aminotransferase Increased: 4 people, 33.33%
  9. Hyperkalemia (damage to or disease of the kidney): 3 people, 25.00%
  10. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and have Microscopic polyangiitis?

- Check whether Microscopic polyangiitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Furosemide:

Microscopic polyangiitis treatments and more:

How severe was Microscopic polyangiitis and when was it recovered:

Expand to all the drugs that have ingredients of furosemide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Microscopic polyangiitis:

Browse all the conditions that are associated with Microscopic polyangiitis:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on furosemide (the active ingredients of Furosemide) and Furosemide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: